对不同药物治疗方案的回顾性观察性研究,以及咳变异性喘儿童的结果
Nannan Lou1, Xiang Ma1,2, Qingxin Luo3,4
1Department of Respiratory Diseases, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital), Jinan, Shandong, China.
Immunity, inflammation and disease
|August 7, 2024
概括
在患有咳变异性喘 (CVA) 的儿童中,吸入性皮质类固醇 (ICS) 加长效β2-激动剂 (LABA) 能在8周内迅速缓解症状. 在8周后,ICS单疗可以有效地长期管理CVA.
科学领域:
- 儿科肺病学 儿科肺病学
- 药物治疗 药物治疗
- 喘管理 喘管理
背景情况:
- 咳变异性喘 (CVA) 在儿童中具有诊断挑战,通常需要量身定制的治疗策略.
- 儿科CVA的最佳治疗方案和持续时间仍然是积极研究的领域.
研究的目的:
- 为了确定最有效的治疗方案和最佳的治疗持续时间,咳变体喘在儿科患者.
- 为了比较不同CVA治疗方案的疗效和症状改善的速度.
主要方法:
- 一项回顾性纵向队列研究,涉及314名被诊断患有心血管梗塞的儿童.
- 患者被分为四组:ICS+LABA,ICS+LTRA,ICS单疗法和LTRA单疗法.
- 统计分析包括后勤回归和Cox比例危险模型来评估治疗结果和复发.
主要成果:
- ICS+LABA组合在治疗的最初8周内表现出最快的症状改善.
- 在ICS+LABA治疗4周,LTRA单疗20周,ICS+LTRA和ICS单疗36周后,观察到显著的症状改善.
- 在8周后,ICS单疗或LTRA单疗的疗效与组合疗法的疗效相当.
结论:
- 吸入性皮质类固醇加长效β2-激动剂 (ICS+LABA) 是在前8周内快速控制心血管梗塞症状的首选方案.
- 在初步改善后,治疗可以降级为ICS单疗,以持续控制CVA,并观察到长达36周的显著症状缓解.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
192
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
192
Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K
Asthma: Pathogenesis and Management
378
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
378
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K


